Mark G. Currie's Insider Trades & SAST Disclosures
Mark G. Currie's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 24,311 Class A Common Stock done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark G. Currie.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,311 | 568,419 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 22,350 | 544,108 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Aug 2022 | 70,000 | 521,758 (0%) | 0% | 11.8 | 824,600 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.65 per share. | 07 Jun 2022 | 190,383 | 782,141 (0%) | 0% | 11.7 | 2,217,962 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 190,383 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 07 Jun 2022 | 190,383 | 591,758 (0%) | 0% | 12.0 | 2,286,500 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,571 | 591,758 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 22,766 | 593,758 (0%) | 0% | 0 | Class A Common Stock | |
| Cyclerion Therapeutics Inc | Mark G. Currie | President and CSO | Sale of securities on an exchange or to another person at price $ 3.01 per share. | 28 Dec 2020 | 20,107 | 251,648 (0%) | 0% | 3.0 | 60,522 | Common Stock |
| Ironwood Pharmaceuticals I... | Mark G. Currie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 21,720 | 570,992 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges